2011
DOI: 10.1097/sla.0b013e31820b01f1
|View full text |Cite
|
Sign up to set email alerts
|

Accuracy of Gadofosveset-enhanced MRI for Nodal Staging and Restaging in Rectal Cancer

Abstract: This study shows high reproducibility and significantly improved accuracy compared to standard MRI for gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
75
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 129 publications
(76 citation statements)
references
References 30 publications
1
75
0
Order By: Relevance
“…Patients with rectal cancer have a 29 to 52 % risk for lymph node metastasis [5][6][7][8] resulting in an inferior long-term survival and a higher risk for local recurrences of the tumor [9][10][11]. Therefore, many studies have focused on the ability to predict pN+ through MRI.…”
Section: Discussionmentioning
confidence: 98%
“…Patients with rectal cancer have a 29 to 52 % risk for lymph node metastasis [5][6][7][8] resulting in an inferior long-term survival and a higher risk for local recurrences of the tumor [9][10][11]. Therefore, many studies have focused on the ability to predict pN+ through MRI.…”
Section: Discussionmentioning
confidence: 98%
“…(Lambregts et al, 2011). Furthermore, a few of these advanced modalities are still inaccessible in developing areas like China.…”
Section: Discussionmentioning
confidence: 99%
“…Many of these compounds are in preclinical development, but at present only MS-325 (gadofosveset), a gadolinium chelate that is chemically modified causing it to bind strongly but reversibly to plasma albumin, is available for clinical use [24]. Lambregts et al [25 ]reported on the use of gadofosveset-enhanced MRI for nodal staging in rectal cancer. When comparing it to histology as the standard, they found that sensitivity and specificity improved from 76 and 82% to 80 and 97%, respectively, when using gadofosveset (p < 0.001).…”
Section: Gadolinium-based Blood Pool Agentsmentioning
confidence: 99%